All Global Research articles can be read in 27 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).
It saddens us to have to report that as a result of receiving a dose of either the Pfizer / BioNTech MRNA vaccine or the Oxford / Astrazeneca Viral Vector (still MRNA technology), a total of twenty women have now had to suffer the grief of having a miscarriage and losing their unborn child.
Adverse reactions to both jabs reported to the MHRA Yellow Card scheme up to the 21st February shows that the number has almost doubled in just seven days when compared with the previous weeks data, which included adverse reactions to both jabs. As of the 14th February 2021, a total of eleven women had lost their baby with three of those being due to the Oxford vaccine and eight of those being due to the Pfizer vaccine.
The MHRA Yellow Card data now shows that the Oxford jab has caused four women to sadly lose their unborn child, an increase of one on the previous weeks data.
However the Pfizer jab has now caused, as of the 21st February, a total of sixteen women to sadly lose their unborn child, a figure which has doubled from the eight seen in the previous week up to the 14th February.
As of the 14th February there had been 8.3 million doses of the Pfizer vaccine administered, with the Oxford jab lagging behind by 1.4 million at just 6.9 million doses administered. But fast forward to the 21st February, a further 1.1 million doses of the Pfizer jab were administered, and a further 1.5 million doses of the Oxford jab.
However the number of adverse reactions to the Oxford jab is nearly double than what has been reported for the Pfizer jab, with 157,637 adverse reactions to the Oxford Jab being reported, compared with 85,179 adverse reactions to the Pfizer jab being reported as of the 21st February 2021.
Whilst the Oxford vaccine outnumbers the Pfizer jab significantly in terms of adverse reactions, the data now clearly shows the Pfizer jab to be much more dangerous when it comes to being administered to pregnant women.